Click for best price
BetaLactam Drugs Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for Beta-Lactam Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Beta-Lactam Drugs. This report contains market size and forecasts of Beta-Lactam Drugs in global, including the following market information:
Global Beta-Lactam Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Beta-Lactam Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Penicillin Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Beta-Lactam Drugs include GlaxoSmithKline plc, Pfizer, Inc., AstraZeneca plc, Merck & Co., Inc., Eli Lilly and Company and Shionogi & Co., Ltd., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Beta-Lactam Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Beta-Lactam Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Beta-Lactam Drugs Market Segment Percentages, by Type, 2022 (%)
Penicillin
Cephalosporins
Carbapenem
Monobacteria
Global Beta-Lactam Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Beta-Lactam Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Beta-Lactam Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Beta-Lactam Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Beta-Lactam Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Beta-Lactam Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline plc
Pfizer, Inc.
AstraZeneca plc
Merck & Co., Inc.
Eli Lilly and Company
Shionogi & Co., Ltd.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Beta-Lactam Drugs, market overview.
Chapter 2: Global Beta-Lactam Drugs market size in revenue.
Chapter 3: Detailed analysis of Beta-Lactam Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Beta-Lactam Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Beta-Lactam Drugs Market, Global Outlook and Forecast 2023-2032 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
62 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Beta-Lactam Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Beta-Lactam Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Beta-Lactam Drugs Overall Market Size
2.1 Global Beta-Lactam Drugs Market Size: 2022 VS 2032
2.2 Global Beta-Lactam Drugs Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Beta-Lactam Drugs Players in Global Market
3.2 Top Global Beta-Lactam Drugs Companies Ranked by Revenue
3.3 Global Beta-Lactam Drugs Revenue by Companies
3.4 Top 3 and Top 5 Beta-Lactam Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Beta-Lactam Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Beta-Lactam Drugs Players in Global Market
3.6.1 List of Global Tier 1 Beta-Lactam Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Beta-Lactam Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Beta-Lactam Drugs Market Size Markets, 2022 & 2032
4.1.2 Penicillin
4.1.3 Cephalosporins
4.1.4 Carbapenem
4.1.5 Monobacteria
4.2 By Type - Global Beta-Lactam Drugs Revenue & Forecasts
4.2.1 By Type - Global Beta-Lactam Drugs Revenue, 2018-2023
4.2.2 By Type - Global Beta-Lactam Drugs Revenue, 2024-2032
4.2.3 By Type - Global Beta-Lactam Drugs Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Beta-Lactam Drugs Market Size, 2022 & 2032
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application - Global Beta-Lactam Drugs Revenue & Forecasts
5.2.1 By Application - Global Beta-Lactam Drugs Revenue, 2018-2023
5.2.2 By Application - Global Beta-Lactam Drugs Revenue, 2024-2032
5.2.3 By Application - Global Beta-Lactam Drugs Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Beta-Lactam Drugs Market Size, 2022 & 2032
6.2 By Region - Global Beta-Lactam Drugs Revenue & Forecasts
6.2.1 By Region - Global Beta-Lactam Drugs Revenue, 2018-2023
6.2.2 By Region - Global Beta-Lactam Drugs Revenue, 2024-2032
6.2.3 By Region - Global Beta-Lactam Drugs Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Beta-Lactam Drugs Revenue, 2018-2032
6.3.2 US Beta-Lactam Drugs Market Size, 2018-2032
6.3.3 Canada Beta-Lactam Drugs Market Size, 2018-2032
6.3.4 Mexico Beta-Lactam Drugs Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Beta-Lactam Drugs Revenue, 2018-2032
6.4.2 Germany Beta-Lactam Drugs Market Size, 2018-2032
6.4.3 France Beta-Lactam Drugs Market Size, 2018-2032
6.4.4 U.K. Beta-Lactam Drugs Market Size, 2018-2032
6.4.5 Italy Beta-Lactam Drugs Market Size, 2018-2032
6.4.6 Russia Beta-Lactam Drugs Market Size, 2018-2032
6.4.7 Nordic Countries Beta-Lactam Drugs Market Size, 2018-2032
6.4.8 Benelux Beta-Lactam Drugs Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Beta-Lactam Drugs Revenue, 2018-2032
6.5.2 China Beta-Lactam Drugs Market Size, 2018-2032
6.5.3 Japan Beta-Lactam Drugs Market Size, 2018-2032
6.5.4 South Korea Beta-Lactam Drugs Market Size, 2018-2032
6.5.5 Southeast Asia Beta-Lactam Drugs Market Size, 2018-2032
6.5.6 India Beta-Lactam Drugs Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Beta-Lactam Drugs Revenue, 2018-2032
6.6.2 Brazil Beta-Lactam Drugs Market Size, 2018-2032
6.6.3 Argentina Beta-Lactam Drugs Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Beta-Lactam Drugs Revenue, 2018-2032
6.7.2 Turkey Beta-Lactam Drugs Market Size, 2018-2032
6.7.3 Israel Beta-Lactam Drugs Market Size, 2018-2032
6.7.4 Saudi Arabia Beta-Lactam Drugs Market Size, 2018-2032
6.7.5 UAE Beta-Lactam Drugs Market Size, 2018-2032
7 Beta-Lactam Drugs Companies Profiles
7.1 GlaxoSmithKline plc
7.1.1 GlaxoSmithKline plc Company Summary
7.1.2 GlaxoSmithKline plc Business Overview
7.1.3 GlaxoSmithKline plc Beta-Lactam Drugs Major Product Offerings
7.1.4 GlaxoSmithKline plc Beta-Lactam Drugs Revenue in Global Market (2018-2023)
7.1.5 GlaxoSmithKline plc Key News & Latest Developments
7.2 Pfizer, Inc.
7.2.1 Pfizer, Inc. Company Summary
7.2.2 Pfizer, Inc. Business Overview
7.2.3 Pfizer, Inc. Beta-Lactam Drugs Major Product Offerings
7.2.4 Pfizer, Inc. Beta-Lactam Drugs Revenue in Global Market (2018-2023)
7.2.5 Pfizer, Inc. Key News & Latest Developments
7.3 AstraZeneca plc
7.3.1 AstraZeneca plc Company Summary
7.3.2 AstraZeneca plc Business Overview
7.3.3 AstraZeneca plc Beta-Lactam Drugs Major Product Offerings
7.3.4 AstraZeneca plc Beta-Lactam Drugs Revenue in Global Market (2018-2023)
7.3.5 AstraZeneca plc Key News & Latest Developments
7.4 Merck & Co., Inc.
7.4.1 Merck & Co., Inc. Company Summary
7.4.2 Merck & Co., Inc. Business Overview
7.4.3 Merck & Co., Inc. Beta-Lactam Drugs Major Product Offerings
7.4.4 Merck & Co., Inc. Beta-Lactam Drugs Revenue in Global Market (2018-2023)
7.4.5 Merck & Co., Inc. Key News & Latest Developments
7.5 Eli Lilly and Company
7.5.1 Eli Lilly and Company Company Summary
7.5.2 Eli Lilly and Company Business Overview
7.5.3 Eli Lilly and Company Beta-Lactam Drugs Major Product Offerings
7.5.4 Eli Lilly and Company Beta-Lactam Drugs Revenue in Global Market (2018-2023)
7.5.5 Eli Lilly and Company Key News & Latest Developments
7.6 Shionogi & Co., Ltd.
7.6.1 Shionogi & Co., Ltd. Company Summary
7.6.2 Shionogi & Co., Ltd. Business Overview
7.6.3 Shionogi & Co., Ltd. Beta-Lactam Drugs Major Product Offerings
7.6.4 Shionogi & Co., Ltd. Beta-Lactam Drugs Revenue in Global Market (2018-2023)
7.6.5 Shionogi & Co., Ltd. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Beta-Lactam Drugs Market Opportunities & Trends in Global Market
Table 2. Beta-Lactam Drugs Market Drivers in Global Market
Table 3. Beta-Lactam Drugs Market Restraints in Global Market
Table 4. Key Players of Beta-Lactam Drugs in Global Market
Table 5. Top Beta-Lactam Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Beta-Lactam Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Beta-Lactam Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Beta-Lactam Drugs Product Type
Table 9. List of Global Tier 1 Beta-Lactam Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Beta-Lactam Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Beta-Lactam Drugs Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Beta-Lactam Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Beta-Lactam Drugs Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global Beta-Lactam Drugs Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - Beta-Lactam Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Beta-Lactam Drugs Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global Beta-Lactam Drugs Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Beta-Lactam Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Beta-Lactam Drugs Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America Beta-Lactam Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Beta-Lactam Drugs Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe Beta-Lactam Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Beta-Lactam Drugs Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia Beta-Lactam Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Beta-Lactam Drugs Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America Beta-Lactam Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Beta-Lactam Drugs Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa Beta-Lactam Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Beta-Lactam Drugs Revenue, (US$, Mn), 2024-2032
Table 30. GlaxoSmithKline plc Company Summary
Table 31. GlaxoSmithKline plc Beta-Lactam Drugs Product Offerings
Table 32. GlaxoSmithKline plc Beta-Lactam Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. GlaxoSmithKline plc Key News & Latest Developments
Table 34. Pfizer, Inc. Company Summary
Table 35. Pfizer, Inc. Beta-Lactam Drugs Product Offerings
Table 36. Pfizer, Inc. Beta-Lactam Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Pfizer, Inc. Key News & Latest Developments
Table 38. AstraZeneca plc Company Summary
Table 39. AstraZeneca plc Beta-Lactam Drugs Product Offerings
Table 40. AstraZeneca plc Beta-Lactam Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. AstraZeneca plc Key News & Latest Developments
Table 42. Merck & Co., Inc. Company Summary
Table 43. Merck & Co., Inc. Beta-Lactam Drugs Product Offerings
Table 44. Merck & Co., Inc. Beta-Lactam Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Merck & Co., Inc. Key News & Latest Developments
Table 46. Eli Lilly and Company Company Summary
Table 47. Eli Lilly and Company Beta-Lactam Drugs Product Offerings
Table 48. Eli Lilly and Company Beta-Lactam Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Eli Lilly and Company Key News & Latest Developments
Table 50. Shionogi & Co., Ltd. Company Summary
Table 51. Shionogi & Co., Ltd. Beta-Lactam Drugs Product Offerings
Table 52. Shionogi & Co., Ltd. Beta-Lactam Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Shionogi & Co., Ltd. Key News & Latest Developments
List of Figures
Figure 1. Beta-Lactam Drugs Segment by Type in 2022
Figure 2. Beta-Lactam Drugs Segment by Application in 2022
Figure 3. Global Beta-Lactam Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Beta-Lactam Drugs Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Beta-Lactam Drugs Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Beta-Lactam Drugs Revenue in 2022
Figure 8. By Type - Global Beta-Lactam Drugs Revenue Market Share, 2018-2032
Figure 9. By Application - Global Beta-Lactam Drugs Revenue Market Share, 2018-2032
Figure 10. By Type - Global Beta-Lactam Drugs Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global Beta-Lactam Drugs Revenue Market Share, 2018-2032
Figure 12. By Application - Global Beta-Lactam Drugs Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global Beta-Lactam Drugs Revenue Market Share, 2018-2032
Figure 14. By Region - Global Beta-Lactam Drugs Revenue Market Share, 2018-2032
Figure 15. By Country - North America Beta-Lactam Drugs Revenue Market Share, 2018-2032
Figure 16. US Beta-Lactam Drugs Revenue, (US$, Mn), 2018-2032
Figure 17. Canada Beta-Lactam Drugs Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico Beta-Lactam Drugs Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe Beta-Lactam Drugs Revenue Market Share, 2018-2032
Figure 20. Germany Beta-Lactam Drugs Revenue, (US$, Mn), 2018-2032
Figure 21. France Beta-Lactam Drugs Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. Beta-Lactam Drugs Revenue, (US$, Mn), 2018-2032
Figure 23. Italy Beta-Lactam Drugs Revenue, (US$, Mn), 2018-2032
Figure 24. Russia Beta-Lactam Drugs Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries Beta-Lactam Drugs Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux Beta-Lactam Drugs Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia Beta-Lactam Drugs Revenue Market Share, 2018-2032
Figure 28. China Beta-Lactam Drugs Revenue, (US$, Mn), 2018-2032
Figure 29. Japan Beta-Lactam Drugs Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea Beta-Lactam Drugs Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia Beta-Lactam Drugs Revenue, (US$, Mn), 2018-2032
Figure 32. India Beta-Lactam Drugs Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America Beta-Lactam Drugs Revenue Market Share, 2018-2032
Figure 34. Brazil Beta-Lactam Drugs Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina Beta-Lactam Drugs Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa Beta-Lactam Drugs Revenue Market Share, 2018-2032
Figure 37. Turkey Beta-Lactam Drugs Revenue, (US$, Mn), 2018-2032
Figure 38. Israel Beta-Lactam Drugs Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia Beta-Lactam Drugs Revenue, (US$, Mn), 2018-2032
Figure 40. UAE Beta-Lactam Drugs Revenue, (US$, Mn), 2018-2032
Figure 41. GlaxoSmithKline plc Beta-Lactam Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Pfizer, Inc. Beta-Lactam Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. AstraZeneca plc Beta-Lactam Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Merck & Co., Inc. Beta-Lactam Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Eli Lilly and Company Beta-Lactam Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Shionogi & Co., Ltd. Beta-Lactam Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
